SISTEMA DE REPORTES DE EVENTOS ADVERSOS [AERS]

FDA Drug Safety Newsletter

MedWatch: The FDA Safety Information and Adverse Event Reporting Program
MedWatch 2008 Safety Alerts
Voluntary Reporting to MedWatch
--------------------------------------------------------------------------------
Adverse Event Reporting System (AERS) --------------------------------------------------------------------------------
This publication provides postmarketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting.
--------------------------------------------------------------------------------
Current Issue:
Volume 2, Number 1, 2009 HTML | PDF
Previous Issues
--------------------------------------------------------------------------------
FDA Drug Safety Newsletter

U.S. Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
Address: 5600 Fishers Lane, Rockville MD 20857-0001
Phone: 1-888-INFO-FDA (1-888-463-6332)

Health professionals report to:
1-800-FDA-1088
1-800-FDA-0178 (FAX)
http://www.fda.gov/medwatch/report.htm

Editorial Staff
Renan A. Bonnel, PharmD, MPH
Gregory D. Busse, PhD

Suggestions?
We value your comments and please let us know by reaching us at
http://www.fda.gov/cder/comment.htm
Page created: September 18, 2007; updated January 15, 2009